152 related articles for article (PubMed ID: 27904972)
1. The Influence of Preoperative Symptoms on the Death of Patients with Small Intestinal Neuroendocrine Tumors.
Eriksson J; Garmo H; Hellman P; Ihre-Lundgren C
Ann Surg Oncol; 2017 May; 24(5):1214-1220. PubMed ID: 27904972
[TBL] [Abstract][Full Text] [Related]
2. Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital.
Folkestad O; Wasmuth HH; Mjønes P; Fougner R; Hauso Ø; Fossmark R
Surg Oncol; 2020 Dec; 35():336-343. PubMed ID: 32979699
[TBL] [Abstract][Full Text] [Related]
3. Upfront surgery of small intestinal neuroendocrine tumors. Time to reconsider?
Daskalakis K; Tsolakis AV
World J Gastroenterol; 2018 Aug; 24(29):3201-3203. PubMed ID: 30090001
[TBL] [Abstract][Full Text] [Related]
4. Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival.
Daskalakis K; Karakatsanis A; Hessman O; Stuart HC; Welin S; Tiensuu Janson E; Öberg K; Hellman P; Norlén O; Stålberg P
JAMA Oncol; 2018 Feb; 4(2):183-189. PubMed ID: 29049611
[TBL] [Abstract][Full Text] [Related]
5. Incidence and prognosis of patients with small intestinal neuroendocrine tumors in a population based nationwide study.
Snorradottir S; Asgeirsdottir A; Rögnvaldsson S; Jonasson JG; Björnsson ES
Cancer Epidemiol; 2022 Aug; 79():102197. PubMed ID: 35716441
[TBL] [Abstract][Full Text] [Related]
6. Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.
Pasquer A; Walter T; Hervieu V; Forestier J; Scoazec JY; Lombard-Bohas C; Poncet G
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S742-9. PubMed ID: 26014153
[TBL] [Abstract][Full Text] [Related]
7. Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study.
Halperin DM; Shen C; Dasari A; Xu Y; Chu Y; Zhou S; Shih YT; Yao JC
Lancet Oncol; 2017 Apr; 18(4):525-534. PubMed ID: 28238592
[TBL] [Abstract][Full Text] [Related]
8. Clinical signs of fibrosis in small intestinal neuroendocrine tumours.
Daskalakis K; Karakatsanis A; Stålberg P; Norlén O; Hellman P
Br J Surg; 2017 Jan; 104(1):69-75. PubMed ID: 27861745
[TBL] [Abstract][Full Text] [Related]
9. Prognostic validity of the American Joint Committee on Cancer staging classification for midgut neuroendocrine tumors.
Strosberg JR; Weber JM; Feldman M; Coppola D; Meredith K; Kvols LK
J Clin Oncol; 2013 Feb; 31(4):420-5. PubMed ID: 23248248
[TBL] [Abstract][Full Text] [Related]
10. Treatment of the carcinoid syndrome by hemihepatectomy and radical excision of the primary lesion.
Gillett DJ; Smith RC
Am J Surg; 1974 Jul; 128(1):95-9. PubMed ID: 4276000
[No Abstract] [Full Text] [Related]
11. Small bowel carcinoid tumors.
Woods HF; Bax ND; Smith JA
World J Surg; 1985 Dec; 9(6):921-9. PubMed ID: 4082614
[No Abstract] [Full Text] [Related]
12. Update on medical treatment of small intestinal neuroendocrine tumors.
Pusceddu S; Femia D; Lo Russo G; Ortolani S; Milione M; Maccauro M; Vernieri C; Prinzi N; Concas L; Leuzzi L; De Braud F; Buzzoni R
Expert Rev Anticancer Ther; 2016 Sep; 16(9):969-76. PubMed ID: 27353232
[TBL] [Abstract][Full Text] [Related]
13. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.
Chambers AJ; Pasieka JL; Dixon E; Rorstad O
Surgery; 2008 Oct; 144(4):645-51; discussion 651-3. PubMed ID: 18847650
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Clinical Prognostic Factors and Further Delineation of the Effect of Mesenteric Fibrosis on Survival in Advanced Midgut Neuroendocrine Tumours.
Laskaratos FM; Walker M; Wilkins D; Tuck A; Ramakrishnan S; Phillips E; Gertner J; Megapanou M; Papantoniou D; Shah R; Banks J; Vlachou E; Garcia-Hernandez J; Woodbridge L; Papadopoulou A; Grant L; Theocharidou E; Watkins J; Luong TV; Mandair D; Caplin M; Toumpanakis C
Neuroendocrinology; 2018; 107(3):292-304. PubMed ID: 30153671
[TBL] [Abstract][Full Text] [Related]
15. The role of surgical management in primary small bowel lymphoma: A single-center experience.
Hong YW; Kuo IM; Liu YY; Yeh TS
Eur J Surg Oncol; 2017 Oct; 43(10):1886-1893. PubMed ID: 28751057
[TBL] [Abstract][Full Text] [Related]
16. Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors.
Modlin IM; Gustafsson BI; Drozdov I; Nadler B; Pfragner R; Kidd M
Ann Surg Oncol; 2009 Feb; 16(2):487-98. PubMed ID: 19050963
[TBL] [Abstract][Full Text] [Related]
17. Progression of metastases and symptom improvement from laparotomy in midgut carcinoid tumors.
Makridis C; Rastad J; Oberg K; Akerström G
World J Surg; 1996 Sep; 20(7):900-6; discussion 907. PubMed ID: 8678969
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of advanced-stage carcinoid tumors: lessons learned.
Boudreaux JP; Putty B; Frey DJ; Woltering E; Anthony L; Daly I; Ramcharan T; Lopera J; Castaneda W
Ann Surg; 2005 Jun; 241(6):839-45; discussion 845-6. PubMed ID: 15912033
[TBL] [Abstract][Full Text] [Related]
19. A nomogram to assess small-intestinal neuroendocrine tumor ('carcinoid') survival.
Modlin IM; Gustafsson BI; Pavel M; Svejda B; Lawrence B; Kidd M
Neuroendocrinology; 2010; 92(3):143-57. PubMed ID: 20733279
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal carcinomatosis from small intestinal neuroendocrine tumors: Clinical course and genetic profiling.
Norlén O; Edfeldt K; Akerstrom G; Westin G; Hellman P; Bjorklund P; Stalberg P
Surgery; 2014 Dec; 156(6):1512-21; discussion 1521-2. PubMed ID: 25456945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
